共 50 条
- [8] Cardiovascular thromboembolic events associated with use of Febuxostat: Investigation of case reports from the FDA adverse event reporting system database. [J]. PHARMACOTHERAPY, 2012, 32 (10): : E232 - E232
- [10] Hypersensitivity reactions to anticancer agents: Data mining of the public version of the FDA adverse event reporting system, AERS [J]. Journal of Experimental & Clinical Cancer Research, 30